These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38832515)

  • 1. Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
    Kazi DS; Elkind MSV; Deutsch A; Dowd WN; Heidenreich P; Khavjou O; Mark D; Mussolino ME; Ovbiagele B; Patel SS; Poudel R; Weittenhiller B; Powell-Wiley TM; Joynt Maddox KE;
    Circulation; 2024 Jul; 150(4):e89-e101. PubMed ID: 38832515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
    Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.
    Heidenreich PA; Trogdon JG; Khavjou OA; Butler J; Dracup K; Ezekowitz MD; Finkelstein EA; Hong Y; Johnston SC; Khera A; Lloyd-Jones DM; Nelson SA; Nichol G; Orenstein D; Wilson PW; Woo YJ; ; ; ; ; ; ; ; ; ; ; ; ;
    Circulation; 2011 Mar; 123(8):933-44. PubMed ID: 21262990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
    Joynt Maddox KE; Elkind MSV; Aparicio HJ; Commodore-Mensah Y; de Ferranti SD; Dowd WN; Hernandez AF; Khavjou O; Michos ED; Palaniappan L; Penko J; Poudel R; Roger VL; Kazi DS;
    Circulation; 2024 Jul; 150(4):e65-e88. PubMed ID: 38832505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association.
    Ovbiagele B; Goldstein LB; Higashida RT; Howard VJ; Johnston SC; Khavjou OA; Lackland DT; Lichtman JH; Mohl S; Sacco RL; Saver JL; Trogdon JG;
    Stroke; 2013 Aug; 44(8):2361-75. PubMed ID: 23697546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
    Mannino DM; Roberts MH; Mapel DW; Zhang Q; Lunacsek O; Grabich S; van Stiphout J; Meadors BL; Feigler N; Pollack MF
    Chest; 2024 May; 165(5):1093-1106. PubMed ID: 38042365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.
    Heidenreich PA; Albert NM; Allen LA; Bluemke DA; Butler J; Fonarow GC; Ikonomidis JS; Khavjou O; Konstam MA; Maddox TM; Nichol G; Pham M; Piña IL; Trogdon JG; ; ; ; ; ;
    Circ Heart Fail; 2013 May; 6(3):606-19. PubMed ID: 23616602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projecting Long-term Health and Economic Burden of COPD in the United States.
    Zafari Z; Li S; Eakin MN; Bellanger M; Reed RM
    Chest; 2021 Apr; 159(4):1400-1410. PubMed ID: 33011203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy.
    Case BC; Bress AP; Kolm P; Philip S; Herrick JS; Granowitz CB; Toth PP; Fan W; Wong ND; Hull M; Weintraub WS
    J Clin Lipidol; 2019; 13(5):754-761. PubMed ID: 31427271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projected costs of ischemic stroke in the United States.
    Brown DL; Boden-Albala B; Langa KM; Lisabeth LD; Fair M; Smith MA; Sacco RL; Morgenstern LB
    Neurology; 2006 Oct; 67(8):1390-5. PubMed ID: 16914694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic costs of diabetes in the US in 2002.
    Hogan P; Dall T; Nikolov P;
    Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.
    Lackland DT; Roccella EJ; Deutsch AF; Fornage M; George MG; Howard G; Kissela BM; Kittner SJ; Lichtman JH; Lisabeth LD; Schwamm LH; Smith EE; Towfighi A; ; ; ;
    Stroke; 2014 Jan; 45(1):315-53. PubMed ID: 24309587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Projected Economic and Health Burden of Uncontrolled Asthma in the United States.
    Yaghoubi M; Adibi A; Safari A; FitzGerald JM; Sadatsafavi M
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1102-1112. PubMed ID: 31166782
    [No Abstract]   [Full Text] [Related]  

  • 15. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of chronic cardiovascular disease for major insurers.
    Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
    Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the United States.
    Qureshi AI; Suri MF; Kirmani JF; Divani AA
    Stroke; 2004 Oct; 35(10):2346-50. PubMed ID: 15345797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future incidence, prevalence and costs of stroke in the UK.
    King D; Wittenberg R; Patel A; Quayyum Z; Berdunov V; Knapp M
    Age Ageing; 2020 Feb; 49(2):277-282. PubMed ID: 31957781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct and indirect diabetes costs in the world].
    Logminiene Z; Norkus A; Valius L
    Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
    Sacco RL; Roth GA; Reddy KS; Arnett DK; Bonita R; Gaziano TA; Heidenreich PA; Huffman MD; Mayosi BM; Mendis S; Murray CJ; Perel P; Piñeiro DJ; Smith SC; Taubert KA; Wood DA; Zhao D; Zoghbi WA
    Circulation; 2016 Jun; 133(23):e674-90. PubMed ID: 27162236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.